Acadian Asset Management LLC Oncternal Therapeutics, Inc. Transaction History

Acadian Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.29 - $0.48 $10,205 - $16,892	-35,192 Reduced 32.6%	72,775 $21,000
Q2 2023 Aug 07, 2023	SELL	$0.28 - $0.79 $16,140 - $45,538	-57,644 Reduced 34.81%	107,967 $36,000
Q1 2023 May 11, 2023	SELL	$0.63 - $1.3 $35,593 - $73,446	-56,497 Reduced 25.44%	165,611 $128,000
Q4 2022 Feb 14, 2023	BUY	$0.86 - $22.2 $24,718 - $638,072	28,742 Added 14.86%	222,108 $220,000
Q3 2022 Nov 14, 2022	BUY	$0.83 - $17.8 $105,065 - $2.25 Million	126,585 Added 189.55%	193,366 $171,000
Q2 2022 Aug 09, 2022	BUY	$0.7 - $1.56 $46,746 - $104,178	66,781 New	66,781 $74,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $63.3M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.